[Leukocyte migration inhibition test in patients with pollen-induced asthma and the results of hyposensitization therapy with Pollinex].
D000485:Allergens / Q000627:therapeutic use*; D052179:Antigens, Plant / Q000627:therapeutic use; D001249:Asthma / Q000276:immunology* / Q000628:therapy; D002464:Cell Migration Inhibition; D003888:Desensitization, Immunologic; D004338:Drug Combinations / Q000627:therapeutic use; D005500:Follow-Up Studies; D005976:Glutaral / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D007962:Leukocytes / Q000276:immunology*; D008517:Phytotherapy; D010936:Plant Extracts; D011058:Pollen / Q000627:therapeutic use; D014443:Tyrosine / Q000627:therapeutic use
D000485:Allergens; D052179:Antigens, Plant; D004338:Drug Combinations; D010936:Plant Extracts; D014443:Tyrosine; C014155:Parietaria judaica pollen; D005976:Glutaral
Test hamowania migracji leukocytów (THML) u chorych na astme pyłkowa z uwzglednieniem wyników leczenia odczulajacego preparatem "Pollinex".